SETD3 is an actin histidine methyltransferase that prevents primary dystocia

Alex W. Wilkinson(Stanford University), Or Gozani(Stanford University), Joshua E. Elias(Chan Zuckerberg Initiative (United States)), Justin Mak(Stanford Health Care), Katherine M. Ruppel(Stanford University), Tina M. Cowan(Stanford University), Xiaodong Cheng(The University of Texas MD Anderson Cancer Center), Shaobo Dai(The University of Texas MD Anderson Cancer Center), James A. Spudich(Stanford University), Jan E. Carette(Stanford Medicine), José G. Vilches-Moure(Stanford University), Kerriann M. Casey(Stanford University), Darshan V. Trivedi(Stanford University), Jonathan Diep(Stanford University), Claude M. Nagamine(Stanford University), Yaw Shin Ooi(Agency for Science, Technology and Research), Tie‐Mei Li(Stanford University), Shuo Liu(King University), Xing Zhang(Northwestern Polytechnical University), J.R. Horton(The University of Texas MD Anderson Cancer Center), Dan Song(Stanford University), Chao Liu(Stanford Medicine)
Nature
December 7, 2018
Cited by 171


Related Papers